Elutia Inc (NAS:ELUT)
$ 3.94 -0.21 (-5.06%) Market Cap: 136.18 Mil Enterprise Value: 133.57 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 56/100

Q1 2021 Aziyo Biologics Inc Earnings Call Transcript

May 04, 2021 / 08:30PM GMT
Release Date Price: $9.51 (-1.55%)
Operator

Welcome to the Aziyo Biologics Q1 2021 Earnings Call. My name is Adrienne, and I'll be your operator for today's call. (Operator Instructions)

I'll now turn the call over to Leigh Salvo, Investor Relations. Leigh, you may begin.

Leigh J. Salvo
Gilmartin Group LLC - MD

Thank you, and thank you all for participating in today's call. Joining me are Ron Lloyd, Chief Executive Officer; and Matt Ferguson, Chief Financial Officer.

Earlier today, Aziyo released financial results for the first quarter ended March 31, 2021. A copy of the press release is available on the company's website.

Before we begin, I'd like to remind you that management will make statements during this call that include forward-looking statements within the meaning of federal securities laws which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any statements contained in this call that do not relate to matters of historical fact or relate to expectations or predictions of future events, results or performance

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot